Scholar Rock Earnings
NASDAQ: SRRKHealthcareBiotechnologyUSD
42.19-0.01 (-0.02%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Scholar Rock earnings summary
In its most recent report on Aug 6, 2026 (Q2 2026), SRRK posted EPS of $-0.84. Revenue for the quarter was $0. Across the last 16 reports, SRRK shares moved an average of 7.0% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
SRRK earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-0.84 | — | -0.8% |
| May 7, 2026 | — | $-0.83 | — | +2.0% |
| Mar 3, 2026 | — | $-0.74 | — | -11.7% |
| Nov 14, 2025 | — | $-0.90 | — | +7.5% |
| Aug 6, 2025 | — | $-0.98 | — | -1.7% |
| May 14, 2025 | — | $-0.67 | — | -1.8% |
| Feb 27, 2025 | — | $-0.62 | — | -7.3% |
| Nov 12, 2024 | — | $-0.66 | — | +12.9% |
| Aug 8, 2024 | — | $-0.60 | — | +10.3% |
| May 7, 2024 | — | $-0.59 | — | -6.4% |
| Mar 19, 2024 | — | $-0.50 | — | +8.4% |
| Nov 7, 2023 | — | $-0.53 | — | +20.8% |
| Aug 9, 2023 | — | $-0.47 | — | -8.8% |
| May 9, 2023 | — | $-0.49 | — | +2.0% |
| Mar 7, 2023 | — | $-0.44 | — | +3.0% |
| Nov 14, 2022 | — | $-0.55 | — | -6.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.